Neupath Health Inc. (TSE:NPTH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
NeuPath Health Inc. reported a revenue increase for both the fourth quarter and full year of 2023, with a 4% rise to $16.8 million in Q4 and a 6% annual growth, totaling $66.1 million. The company achieved its 20th consecutive quarter of positive adjusted EBITDA at $0.8 million and more than doubled its cash balance to $3.2 million year-over-year. Additionally, NeuPath has expanded its operations by acquiring the London Spine Centre, enhancing its network of chronic pain treatment clinics.
For further insights into TSE:NPTH stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue